Solvent Sample Analysis: ÀÌ °á°ú´Â ÷°¡ÇÑ »ùÇðú ÄÁÆ®·Ñ »ùÇà »çÀÌ¿¡ ±¸º°µÇ´Â Â÷ÀÌÁ¡À» º¸¿©ÁØ´Ù(Figure 4). ChemSpider °Ë»öÀº ¼¼ Á¾·ùÀÇ ¼ººÐÀÎ Strychnine, Colchicine°ú AconitineÀ» External CalibrationÁ¶°Ç¿¡¼­ Á¤È®µµ 2ppm ³»¿¡¼­ ¿Ã¹Ù¸£°Ô È®ÀεǾúÀ½À» º¸¿©ÁÖ¾ú´Ù. ÷°¡ÇÑ Á¾·ùÀÇ µ¶¼º¼ººÐÀ¸·Î ¾ð±ÞµÈ Colchicine°ú AconitineÀº ªÀº GradientÀÎ UHPLC Chromatograms Á¶°Ç¿¡¼­ °¢ÀÚ ´Ù¸¥ ¹°Áúµé°ú °ãÄ¡°Ô ºÐ¸®µÇ´õ¶óµµ ChemSpiderÀÇ ¿Â¶óÀÎ µ¥ÀÌÅͺ£À̽ºÀÎ KEGG¿Í Sigma-Aldrich¿¡¼­ °Ë»öµÉ ¶§ »ùÇôëºñ ÄÁÆ®·Ñ »ùÇà »çÀÌ¿¡ Differential Analysis¸¦ °ÅÃÄ SIEVE ¼ÒÇÁÆ®¿þ¾î·Î Á¤È®ÇÏ°Ô È®ÀÎ ÇÒ ¼ö ÀÖ´Ù.


FIGURE 4. Chromatographic Alignment,
Frame and PCA Analysis of Solvent Sample1 Spiked with 3 Toxins


FIGURE 5. Identified Toxin1-Strychnine(m/z 335.1751) in Solvent Sample

FIGURE 6. Identified Toxin2-Colchicine(m/z 400.1749) and Toxin3-Aconitine (m/z 646.3215) in Solvent Sample

Apple Juice Sample Analysis: µÎ °¡Áö µ¶¼º¹°ÁúÀ» »ç°úÁÖ½º¿¡ ÷°¡Çß´Ù. ±ú²ýÇÑ »ç°úÁÖ½º ¸ÅÆ®¸¯½º¸¦ ´ëºñÇÏ¿© ¼¼ ¹ø¾¿ ¹Ýº¹½ÇÇè ÇÏ¿´´Ù. ±× °á°ú´Â Figures 7,8°ú 10¿¡¼­ º¸¿©ÁØ´Ù. LobelineÀº ù¹øÂ°·Î ÷°¡ÇÑ µ¶¼º¹°Áú·Î ºü¸£°í ½±°Ô È®ÀÎÇß´Ù(Figure 8). ¾Æ¿ï·¯, LobelineÀÇ ±Ô¸íÀº MS/MS ÇØ¼®À» ¹ÙÅÁÀ¸·Î Á¤È®ÇÏ°Ô È®ÀÎÇß´Ù(Figure 9).


FIGURE 7. Apple Juice Sample-PCA Analysis


FIGURE 8. Identified Toxin1-Lobeline(m/z 338.2113)
in Apple Juice Sample


FIGURE 9. Annotated MS/MS spectrum of Lobeline(m/z 338.2113)

»ç°úÁÖ½º »ùÇÿ¡¼­, Solanine m/z 868.5031°ú À̰ÍÀÇ In-Source Fragmentation À̿µéÀº Á¦ 2ÀÇ µ¶¼º ¼ººÐ°ú °°Àº Solanadine m/z 398.3410, 560.3936, 561.3970 (n+1 isotope of 560.3936)À» 3.26min¿¡ µ¿½Ã¿¡ ºÐ¸®µÇ¾î ³ª¿Â °Í¿¡¼­ È®ÀÎÇß´Ù.


FIGURE 10. Identification of Toxin2-Solanine(m/z 868.5031) and its In-Source Fragment Solanadine(m/z 398.3410) in Apple Juice Sample

FIGURE 11. MS/MS Spectrum of m/z 868.5031

•  ¼¼ Á¾·ùÀÇ µ¶¼º¼ººÐÀ» Acetonitrile ¿ë¸Å¿¡ ÷°¡ÇÑ »ùÇðú µÎ °¡ÁöÀÇ µ¶¼º ¼ººÐÀ» »ç°úÁÖ½º¿¡ ÷°¡ÇÑ »ùÇÃÀº Q Exactive MSÀÇ ºÐÇØ´É 70,000¿¡¼­ Full ScanÇÑ °Í°ú ºÐÇØ´É 17,500¿¡¼­ Top1 MS/MS·Î ¼¼ ¹ø¾¿ ¹Ýº¹ ½ÇÇèÇØ¼­ ºÐ¼®Çß´Ù.
•  È®ÀÎµÈ µ¶¼º½Ã·áµéÀº ¸ðµÎ External Mass Calibration¿¡¼­ Áú·® Á¤È®µµ 2ppmÀ̳» °ËÃâµÇ¾ú´Ù.
•  ÷°¡ÇÑ µ¶¼º¼ººÐÀº SIEVE ¼ÒÇÁÆ®¿þ¾î¸¦ ÅëÇØ ½ºÅ©¸®´× µÇ¾ú´Ù. ´Ù¼¸ °¡ÁöÀÇ ¹ÌÁö½Ã·á Áß ³× °¡Áö ¼ººÐÀÇ °ËÃâÀº ¼Õ½±°í Á¤È®ÇÏ°Ô ¾ò¾ú´Ù. ¾Æ¿ï·¯, ´Ù¸¥ µ¶¼º¹°ÁúÀº µ¿½Ã ºÐ¸®¿Í ÇÔ²² À̰͵éÀÇ In-Source Fragmentation Products·Î È®ÀÎÇß´Ù.
•  MS/MS¸¦ À§ÇÑ Precursor À̿ ¼±ÅÃÀÇ ±â´É°ú ÇÔ²² Q Exactive MS·ÎºÎÅÍ ¾òÀº HR/AM µ¥ÀÌÅÍ´Â ¹ÌÁöÀÇ µ¶¼º½Ã·á¸¦ ¸Å¿ì ½Å·Ú¼º ÀÖ°Ô ½ºÅ©¸®´× ÇÒ »Ó¸¸ ¾Æ´Ï¶ó, Çѹø ½Ã·á ÁÖÀÔÀ¸·Îµµ ±¸Á¶ÀûÀÎ ÇØ¼®À» ½±°Ô ÇÒ ¼ö ÀÖ´Ù.